Cas 1356625-87-0,N-(1-(4-cyanobenzyl)piperidin-4-yl)-5-(4-(4-cyanophenoxy)piperidin-1-yl)picolinamide

1356625-87-0

Post Buying Request

Basic information

Product Name: N-(1-(4-cyanobenzyl)piperidin-4-yl)-5-(4-(4-cyanophenoxy)piperidin-1-yl)picolinamide
Synonyms: N-(1-(4-cyanobenzyl)piperidin-4-yl)-5-(4-(4-cyanophenoxy)piperidin-1-yl)picolinamide
CAS NO:1356625-87-0
Molecular Formula:
Molecular Weight: 520.634
EINECS: N/A
Product Categories: N/A
Mol File: 1356625-87-0.mol
Article Data: 2

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: N-(1-(4-cyanobenzyl)piperidin-4-yl)-5-(4-(4-cyanophenoxy)piperidin-1-yl)picolinamide(CAS DataBase Reference)
NIST Chemistry Reference: N-(1-(4-cyanobenzyl)piperidin-4-yl)-5-(4-(4-cyanophenoxy)piperidin-1-yl)picolinamide(1356625-87-0)
EPA Substance Registry System: N-(1-(4-cyanobenzyl)piperidin-4-yl)-5-(4-(4-cyanophenoxy)piperidin-1-yl)picolinamide(1356625-87-0)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1356625-87-0(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1356625-87-0 Suppliers

Recommended suppliersmore

1356625-87-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1356625-87-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,5,6,6,2 and 5 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1356625-87:
(9*1)+(8*3)+(7*5)+(6*6)+(5*6)+(4*2)+(3*5)+(2*8)+(1*7)=180
180 % 10 = 0
So 1356625-87-0 is a valid CAS Registry Number.

1356625-87-0Upstream product

1356625-87-0Downstream Products

1356625-87-0Relevant articles and documents

METHODS FOR USING AND BIOMARKERS FOR AMPK-ACTIVATING COMPOUNDS

-

Paragraph 0342, (2015/03/31)

Disclosed are methods of using AMPK-activating compounds, for example, in the treatment of cancer and disorders of vascular flow. Also disclosed are biomarkers for AMPK and uses thereof, for example, in the diagnosis and treatment of AMPK-linked disorders

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1356625-87-0